Citius Pharmaceuticals Stock Price

0.01 (0.84%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,102,740
Bid Price 1.15
Ask Price 1.20
News -
Day High 1.22


52 Week Range


Day Low 1.08
Company Name Stock Ticker Symbol Market Type
Citius Pharmaceuticals Inc CTXR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.01 0.84% 1.20 19:28:21
Open Price Low Price High Price Close Price Prev Close
1.13 1.08 1.22 1.17 1.19
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,266 1,102,740 $ 1.17 $ 1,290,750 - 0.8306 - 2.35
Last Trade Time Type Quantity Stock Price Currency
19:13:08 18 $ 1.20 USD


Draw Mode:

Citius Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 175.36M 146.13M 133.82M $ - $ - -0.27 -5.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 8.40%

more financials information »

Citius Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTXR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.99531.220.9331.081,048,7130.204720.57%
1 Month0.911.220.86010.9834853752,2380.2931.87%
3 Months0.89761.220.83060.957421,151,7210.302433.69%
6 Months1.512.010.83061.241,539,514-0.31-20.53%
1 Year1.832.350.83061.601,790,135-0.63-34.43%
3 Years1.174.560.401.963,391,1320.032.56%
5 Years2.915.490.401.962,091,339-1.71-58.76%

Citius Pharmaceuticals Description

Citius Pharmaceuticals, Inc. is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Your Recent History
Citius Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now